US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Oct 13, 2025 (11 months ago)

Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent drug; Clavulanate Potassium component

What was recalled

Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.

Recalling firm
Teva Pharmaceuticals USA, Inc
NDC code
0093-2277-7
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0151-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Amoxicillin recalls

See all